Celldex Therapeutics SG&A Expense (Quarterly) Insights

Celldex Therapeutics Inc (CLDX)

36.55 -0.47 (-1.27%) USD | NASDAQ | Apr 25, 10:18

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1990. Upgrade now.

Date	Value
December 31, 2023	8.832M
September 30, 2023	8.221M
June 30, 2023	7.221M
March 31, 2023	6.64M
December 31, 2022	6.599M
September 30, 2022	6.531M
June 30, 2022	7.154M
March 31, 2022	6.911M
December 31, 2021	6.241M
September 30, 2021	5.821M
June 30, 2021	4.306M
March 31, 2021	4.121M
December 31, 2020	3.623M
September 30, 2020	3.64M
June 30, 2020	3.528M
March 31, 2020	3.666M
December 31, 2019	3.219M
September 30, 2019	3.403M
June 30, 2019	3.908M
March 31, 2019	4.896M
December 31, 2018	4.333M
September 30, 2018	3.722M
June 30, 2018	5.621M
March 31, 2018	5.593M
December 31, 2017	5.894M

Date	Value
September 30, 2017	5.346M
June 30, 2017	6.534M
March 31, 2017	7.229M
December 31, 2016	11.93M
September 30, 2016	6.95M
June 30, 2016	7.79M
March 31, 2016	9.307M
December 31, 2015	11.08M
September 30, 2015	8.487M
June 30, 2015	8.184M
March 31, 2015	6.089M
December 31, 2014	6.249M
September 30, 2014	5.004M
June 30, 2014	4.787M
March 31, 2014	4.582M
December 31, 2013	4.677M
September 30, 2013	3.578M
June 30, 2013	3.411M
March 31, 2013	3.138M
December 31, 2012	2.644M
September 30, 2012	2.835M
June 30, 2012	2.219M
March 31, 2012	2.317M
December 31, 2011	-4.417M
September 30, 2011	4.591M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

3.219M

Minimum

Dec 2019

8.832M

Maximum

Dec 2023

5.452M

Average

5.821M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks